10x Genomics unveiled its Atera spatial platform at AACR 2026, pitching whole-transcriptome spatial biology at higher throughput and plex than its prior Xenium system. The company said Atera “obliterates” typical trade-offs in spatial tools, enabling larger-scale tissue profiling with stackable targeted panels alongside whole-transcriptome workflows. Atera is priced at $495,000, with orders open and availability planned for the second half of the year. 10x positioned the platform to support higher sensitivity and more imageable area per slide, targeting broader adoption in translational research and drug development. For biopharma and research groups, the release signals continued acceleration in spatial assays that can tie gene-expression programs to microenvironments—an input increasingly used for target validation, biomarker discovery, and companion diagnostic development.